Stewart M. Kroll

2012

In 2012, Stewart M. Kroll earned a total compensation of $602.8K as Senior Vice President of Biostatistics and Clinical Operations at Threshold Pharmaceuticals, a 31% increase compared to previous year.

Compensation breakdown

Bonus$106,459
Option Awards$183,707
Salary$311,969
Other$680
Total$602,815

Kroll received $312K in salary, accounting for 52% of the total pay in 2012.

Kroll also received $106.5K in bonus, $183.7K in option awards and $680 in other compensation.

Rankings

In 2012, Stewart M. Kroll's compensation ranked 8,108th out of 11,487 executives tracked by ExecPay. In other words, Kroll earned more than 29.4% of executives.

ClassificationRankingPercentile
All
8,108
out of 11,487
29th
Division
Manufacturing
2,930
out of 4,253
31st
Major group
Chemicals And Allied Products
773
out of 1,203
36th
Industry group
Drugs
551
out of 925
40th
Industry
Pharmaceutical Preparations
432
out of 700
38th
Source: SEC filing on April 2, 2013.

Kroll's colleagues

We found six more compensation records of executives who worked with Stewart M. Kroll at Threshold Pharmaceuticals in 2012.

2012

Harold Selick

Threshold Pharmaceuticals

Chief Executive Officer

2012

Tillman Pearce

Threshold Pharmaceuticals

Chief Medical Officer

2012

Robert Simon

Threshold Pharmaceuticals

Senior Vice President, Regulatory Affairs and Quality Assurance

2012

Joel Fernandes

Threshold Pharmaceuticals

Vice President, Finance & Controller

2012

Mark Matteucci

Threshold Pharmaceuticals

Senior Vice President, Discovery Research

2012

Nipun Davar

Threshold Pharmaceuticals

Senior Vice President, Pharmaceutical Development and Manufacturing

You may also like